AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05952830 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ESWT group
Description: subjects in ESWT-group receiving one session shock wave therapy given 6,000 impulses at 0.06-0.07 mJ/mm2 (1.2-1.4 bar) at 18 Hz on biceps brachii (17). Subjects in DN-group receiving dry needling using disposable stain less steel sterilized needles, 0.25×0.30. DN perform with patients in supine position, arm away from the trunk, and forearm in supination. The fast-in and fast-out cone shape technique adopt and each muscle needled for one minute
Study NCT05952830 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DN group
Description: Subjects in DN-group receiving dry needling using disposable stain less steel sterilized needles, 0.25×0.30. DN perform with patients in supine position, arm away from the trunk, and forearm in supination. The fast-in and fast-out cone shape technique adopt and each muscle needled for one minute
Study NCT05585307 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GS-6212
Description: Administered orally
Study NCT05585307 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Standard of Care (Substudy 03)
Description: Antiretroviral therapy, administered orally
Study NCT05244590 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Consultation model for patients with palliative care needs
Description: Training in PC for GPs The training program for GPs will meet the main training needs of GPs according to our previous study and feedback from elements of the Palliative Care Study Group of the Portuguese Association of General and Family Medicine (GESPal). The training program will have a total duration of 24 hours and will consist of two modules.~Consultation model for patients Consultations will take place every 3 weeks for a total period of 12 weeks. The consultation model will be divided into five areas (Summarize clinical information, Objective symptoms' management, Assessment and coding of chronic diseases and symptoms, planning clinical approach, (other) problems/concerns) to be addressed during the assessment. The five areas were constructed to be intuitive for GPs, following the records' structure used in Portuguese primary care.
Study NCT05932433 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Each session (45 minutes aprox) is made by: mobility, endurance and final exercise to rest. The sesion is going to perform twice a week during 6 weeks.
Study NCT05508425 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: oral glucose tolerance test using water at room temperature
Description: The use of water at room temperature to solve the 75g glucose.
Study NCT05392075 — intervention group
Intervention type: BIOLOGICAL
Intervention: Pfizer COVID-19 mRNA vaccine
Description: vaccinated people who received the Pfizer COVID-19 mRNA vaccine
Study NCT05392075 — intervention group
Intervention type: BIOLOGICAL
Intervention: Moderna COVID-19 mRNA vaccine
Description: vaccinated people who received the Moderna COVID-19 mRNA vaccine vaccine
Study NCT05028608 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elinzanetant (BAY3427080)
Description: Elinzanetant given orally as a single dose in Period 1 and in Period 2.
Study NCT05028608 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Midazolam given orally as single dose in Period 1 and in Period 2.
Study NCT05028608 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Description: Carbamazepine given orally twice daily in Period 2 .
Study NCT05508425 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: oral glucose tolerance test using hot water
Description: The use of hot water to solve the 75g glucose.
Study NCT06532877 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy
Description: Patients and caregivers in the acceptance and commitment therapy arm learn new and more adaptive ways to respond to difficult internal experiences (e.g., fatigue, thoughts, and feelings).
Study NCT06532877 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Education/Support
Description: Patients and caregivers in the education/support arm discuss their cancer-related concerns and receive education on services available in their medical center and community.
Study NCT05635448 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Better Together Physician Coaching Program
Description: thought-based coaching. This type of coaching focuses on thoughts and beliefs. It combines a cognitive behavioral therapy (CBT) model with mindfulness-based awareness and integrates theories of acceptance and commitment therapy (ACT), nonattachment, and radical questioning from Socratic and Greek philosophies. BT delivers a robust coaching experience via a 4-month web-based, group-coaching model. This novel program allows residents to participate as actively as they are inclined and able, offering flexibility via multiple modalities of coaching: twice weekly group coaching calls, unlimited anonymous written coaching, and weekly self-study modules that are housed on a secure members-only website.
Study NCT06398639 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Polygenic Risk Score (PRS)
Description: Participants will be put into PRS cohorts based on their genetic data.~All participants enrolled into the study will receive a PSA screening test and an mpMRI, regardless of their polygenic risk score.
Study NCT06177353 — intervention group
Intervention type: OTHER
Intervention: Sampling
Description: Blood sampling Skin biopsy Collection of soiled bandages
Study NCT05508425 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: oral glucose tolerance test using cold water
Description: The use of cold water to solve the 75g glucose.
Study NCT05508425 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: oral glucose tolerance test using hot water with tea bag
Description: The use of hot water with tea bag to solve the 75g glucose.
Study NCT05508425 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: oral glucose tolerance test using room temperature water with tea bag
Description: The use of room temperature water with tea bag to solve the 75g glucose.
Study NCT05508425 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: oral glucose tolerance test using cold water with tea bag
Description: The use of cold water with tea bag to solve the 75g glucose.
Study NCT05508425 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Oral glucose tolerance test using bubble water at room temperature
Description: The use of bubble water at room temperature to solve the 75g glucose.
Study NCT05508425 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Oral glucose tolerance test using bubble water
Description: The use of cold bubble water to solve the 75g glucose.
Study NCT05635448 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: No intervention - waitlist control
Description: No intervention - waitlist control
Study NCT05172947 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Resveratrol
Description: This group received resveratrol with the conventional therapy
Study NCT05172947 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: This group received placebo with the conventional therapy
Study NCT05172947 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Resveratrol plus Pharmaceutical care
Description: This group received Resveratrol with Pharmaceutical care in addition to the conventional therapy
Study NCT05172947 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Placebo+Pharmaceutical care
Description: This group received placebo with Pharmaceutical care in addition to the conventional therapy
Study NCT05004740 — intervention group
Intervention type: OTHER
Intervention: Vaccinated Pregnant or Lactating persons
Description: vaccinated lactating persons from Sinai Health System or the general public
Study NCT05060042 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whole body vibration group
Description: WBV will be provided with a frequency of 6-26Hz with amplitude of 1-3mm 4-5 bouts(60 sec each) for 3 times a week
Study NCT05060042 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bilateral proprioceptive training
Description: Static balance training will be provided in first week for 3-4 times for 10 mints of single session. 3 times a week In 2nd and 3rd week dynamic balance training for 3 times with a session of 10 mints.~In 4th week progressive balance training will be done with same frequency and duration.~Tai chai exercises will be given for 20 mints 3 times a week
Study NCT05428371 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Multiomic analyses of blood and surgical specimens
Description: The following items will be evaluated:~* cell free dna length and integrity~* presence or absence of SNPs in cfDNA and in DNA extracted from surgical samples~* qualitative and quantitative evaluation of serum and surgical specimens proteome (proteomics)
Study NCT06584279 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Biopsy of the prostate and pathological diagnosis
Description: Whether the index-lesion-contralateral systematic biopsy was performed
Study NCT04945382 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Scotchbond Universal 3M
Description: The occlusal surfaces will be cleaned using water, a brush and a low-pressure handpiece; they will wash and dry; then deproteinization will be done with sodium hypochlorite (5.25%) for 60 seconds, it will be washed with a water / air spray for 30s; it will dry up; The tooth will then be etched using a 37% orthophosphoric acid gel for 15 seconds, rinsed with a water / air spray for 30 seconds, and dried with cotton balls. Scotchbond universal 3M to the etched surface will be dried under a gentle air flow for 2-3 s, and light cured for 11 s using an LED curing unit with an output of 1500 mW / cm2 (Balloon.).
Study NCT06524947 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: quadrivalent recombinant norovirus vaccine (Pichia pastoris) placebo
Description: Subjects were given three doses of quadrivalent recombinant norovirus vaccine (Pichia pastoris) placebo at a 30-day interval.~Main ingredients: aluminum hydroxide adjuvant, histidine, sodium chloride, tween 80, disodium phosphate, disodium hydrogen phosphate
Study NCT04945382 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Single Bond 3M
Description: The occlusal surfaces will be cleaned using water, a brush and a low-pressure handpiece; they will wash and dry; then deproteinization will be done with sodium hypochlorite (5.25%) for 60 seconds, it will be washed with a water / air spray for 30s; it will dry up; The tooth will then be etched using a 37% orthophosphoric acid gel for 15 seconds, rinsed with a water / air spray for 30 seconds, and dried with cotton balls. Single Bond 3M to the etched surface will be dried under a gentle air flow for 2-3 s, and light cured for 11 s using an LED curing unit with an output of 1500 mW / cm2 (Balloon.).
Study NCT00850512 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CHOP21-R
Description: Four months for CHOP21-R and two treatment days one week apart
Study NCT00850512 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zevalin
Description: 12-week safety period for Zevalin
Study NCT05629962 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bemnifosbuvir (BEM)
Description: BEM tablets administered orally every 12 hours (twice a day) for a total of 5 days
Study NCT05629962 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablets administered orally every 12 hours (twice a day) for a total of 5 days
Study NCT04705480 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pregabalin 50mg
Description: Patients will receive 50 mg every 8 hours without dose titration. Patients with CrCl \< 60mL/min will receive same dose given q12 hours. The q12 hour regimen may be increased to q8 hours if CrCl increases above 60mL/min during the 7 days study period or until discharge (if \< 7 days post-enrollment).
Study NCT04705480 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gabapentin 300mg
Description: Patients will receive 300 mg PO every 8 hours without dose titration. Patients with CrCl \< 60mL/min will receive same dose given q12 hours. The q12 hour regimen may be increased to q8 hours if CrCl increases above 60mL/min during the 7 days study period or until discharge (if \< 7 days post-enrollment).
Study NCT04705480 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neither Pregabalin nor Gabapentin
Description: Patients will receive neither Pregabalin nor Gabapentin.
Study NCT04894383 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Aetrex L420 Compete Orthotic
Description: An orthotic insole to be inserted into shoes. Orthotic for low arches to flat feet with no forefoot pain, featuring a posted heel to control over-pronation and provide balance. Features Aetrex Arch Support to help biomechanically align the body \& help prevent common foot pain such as Plantar Fasciitis, Arch Pain and Metatarsalgia.
Study NCT04894383 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Aetrex L420 Compete Orthotic
Description: An orthotic insole to be inserted into shoes. Orthotic for low arches to flat feet with no forefoot pain, featuring a posted heel to control over-pronation and provide balance. Features Aetrex Arch Support to help biomechanically align the body \& help prevent common foot pain such as Plantar Fasciitis, Arch Pain and Metatarsalgia.
Study NCT04894383 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Aetrex indoor comfort sandal with built-in arch support
Description: An indoor comfort sandal with built-in arch support to be used at home. Provides extreme cushioning, shock absorption and durability. Arch support helps to stabilize and align feet and also helps to relieve common foot pain \& plantar fasciitis.
Study NCT04873583 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Description: At the time of inclusion, intravenous Methylprednisolone for 3 days. Dose: 30 mg/kg/day (max. 1000 mg/dose)
Study NCT04873583 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisolone
Description: Intravenous treatment will be immediately followed by oral tapering with Prednisolone.~Oral Prednisolone, 2 weeks (week 1 and 2) Dose: 1 mg/kg/day (max 40 mg/day) Oral Prednisolone, 2 weeks (week 3 and 4) Dose: 0.5 mg/kg/day (max 20 mg/day)
Study NCT06565624 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cotton Swab Nasal Stimulation
Description: Nostril probing for the purpose of producing reflex tearing
Study NCT05841004 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Investigational device
Description: Ready-to-use, sterile, hydrophilic coated intermittent female compact catheter (sizes CH12 and CH14) for urinary drainage. The investigational device is for single use.
Study NCT05444244 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Relational Research Recruitment and Engagement Intervention
Description: * Specified recruiter/point of contact~* Flexibility in study time, place, method of recruitment (preferred participant email, phone), and follow-up (in registry, if participant calls back at all restart 3 failed phone contacts)~* Resource matching (financial, transportation constraints)
Study NCT01011686 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ANT-SM
Description: autologous adipose-derived stem cell
Study NCT05880914 — intervention group
Intervention type: PROCEDURE
Intervention: miRNAseq analysis
Description: Identify miRNA in serum and prepare a miRNA sequencing library for novel analysis.
Study NCT05880914 — intervention group
Intervention type: DRUG
Intervention: Standard treatment for bone disorder
Description: Participants will be prescribed a clinically indicated bone-targeted treatment for osteoporosis or bone disorder related to CKD. (non-experimental)
Study NCT05032508 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaïne Aguettant 20 mg/ml
Description: Lidocaïne Aguettant 20 mg/ml, injectable solution, applied to the skin with an impregnated compress, applied 15 minutes before infiltration performed by an experienced operator.
Study NCT05032508 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: NaCl 0,9%
Description: Placebo (NaCl 0,9%), applied to the skin with an impregnated compress, applied 15 minutes before infiltration performed by an experienced operator.
Study NCT04874740 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT05841004 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Investigational device
Description: Ready-to-use, sterile, hydrophilic coated intermittent female compact catheter (sizes CH12 and CH14) for urinary drainage. The investigational device is for single use.
Study NCT05841004 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Comparator device
Description: Hollister Infyna Chic, single-use compact catheter.
Study NCT05841004 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Comparator device
Description: Hollister Infyna Chic, single-use compact catheter.
Study NCT06392230 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral [14C] PF-06821497
Description: A single oral dose of \[14C\] PF-06821497 will be administered as an extemporaneous suspension in Period 1
Study NCT06392230 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral PF-06821497
Description: A single oral dose of PF-06821497 will be administered as an extemporaneous oral suspension in Period 2
Study NCT06392230 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV [14C] PF-06821497
Description: A single IV infusion of \[14C\] PF-06821497 will be administered at the Tmax after administration of the unlabeled oral dose of PF-06821497 in Period 2
Study NCT06369961 — intervention group
Intervention type: DRUG
Intervention: transdermal fentanyl
Description: Adult cancer pain patients switched from oral opioid to TDF
Study NCT05924477 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sulcus tube placement
Description: GDD implantation surgery with tube placement in the ciliary sulcus
Study NCT05924477 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Anterior chamber (AC) tube placement
Description: GDD implantation surgery with tube placement in the anterior chamber
Study NCT04918693 — intervention group
Intervention type: DEVICE
Intervention: Ultrasound scanning
Description: All participants will scan with and without device and trainee on 4 models. The order of the device assistance and models will be randomized between participants, but participant will always have exposure to device first before supervising the trainee.
Study NCT05612997 — intervention group
Intervention type: OTHER
Intervention: Dietary Assessment
Description: Food Frequency Questionnaire and 24h Recalls.
Study NCT06508632 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mandala group
Description: Individual mandala activity will be carried out in all sample groups after admission to the clinic where they come to receive outpatient chemotherapy and when they start taking medication. Children will color (paint).
Study NCT04947280 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Fractionated Stereotatic Radiation Therapy
Description: Participants prescribed to receive 9 Gy x 3 or 10 Gy x3 image-guided fractionated stereotatic radiation therapy.
Study NCT05364021 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LP352
Description: LP352 administered three times daily, orally or through G-tube
Study NCT05364021 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo for LP352 administered three times daily, orally or through G-tube
Study NCT04538482 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: DASH Diet
Description: Participant will receive foods following the DASH dietary pattern for 28 days.
Study NCT04538482 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: standard American diet
Description: Participants will receive foods following the standard American diet for 28 days.
Study NCT05961709 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Given by IV (vein)
Study NCT06016062 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RC148 Monotherapy
Description: RC148 injection will be administered as an intravenous (IV) infusion on Day 1 of each 3-week cycle
Study NCT06016062 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RC148+docetaxel Combination Therapy
Description: RC148 injection will be administered as an intravenous (IV) infusion on Day 1 of each 3-week cycle； Docetaxel will be administered as an IV infusion on Day 1 of each 3-week cycle.
Study NCT06016062 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RC148+RC48 Combination Therapy
Description: RC148 injection will be administered as an intravenous (IV) infusion on Day 1 of each 2-week cycle； RC48 will be administered as an IV infusion on Day 1 of each 2-week cycle.
Study NCT06016062 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RC148+RC88 Combination Therapy
Description: RC148 injection will be administered as an intravenous (IV) infusion on Day 1 of each 3-week cycle； RC88 will be administered as an IV infusion on Day 1 of each 3-week cycle.
Study NCT05240937 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mindfulness-based self-compassion will be applied
Description: A mindfulness-based self-compassion program will be applied to this group of patients who have had breast cancer and have fully completed their treatment.
Study NCT06010667 — intervention group
Intervention type: DRUG
Intervention: Envafolimab
Description: With or without Envafolimab